GMP Pure Multi Strain Probiotics 50B CFU Hard Capsules
Acid-resistant, delayed-release HPMC caps carrying 50 Billion verified CFU. Target microbiota integrity to promote optimal intestinal NAD precursor assimilation.
Engineered to international cGMP, ISO 22000, and HACCP benchmarks, ready for seamless deployment into Daejeon’s bio-tech cross-border channels and specialized health retail.
Acid-resistant, delayed-release HPMC caps carrying 50 Billion verified CFU. Target microbiota integrity to promote optimal intestinal NAD precursor assimilation.
Lipophilic botanical matrices containing standardized fatty acids and microencapsulated lycopene for clinical-tier endocrine and cellular longevity support.
High-absorption chelated magnesium engineered with standardized Withanolides and montmorency phytocompounds to reset circadian NAD metabolome rhythms.
Potent natural CD38 inhibitor (Apigenin 98%) coupled with bioavailable bisglycinate to conserve intracellular NAD stores across deep neurological restorative phases.
Standardized 24/6 flavone glycosides and terpene lactones matrix designed for microvascular perfusion, augmenting ATP and mitochondrial coenzyme delivery.
Pharmaceutical-grade stabilized D3 supporting genomic maintenance, telomere transcription stability, and synergistic systemic immunometabolic regulation.
Next-generation mitophagy activator coupled with Pyrroloquinoline Quinone to trigger mitochondrial biogenesis along the PGC-1α pathway alongside NAD boosting.
80% UV-tested Silymarin with concentrated Silybin fraction to bolster hepatic glutathione reserves and maintain endogenous phase I/II methyl group clearance.
Why Daedeok Innopolis, KAIST research spin-offs, and Yuseong-gu commercial entities are reshaping the procurement architecture for cellular cofactors across East Asia.
Daejeon serves as South Korea's premier scientific epicenter, housing over 25 national research institutes and 1,000+ commercial biotech ventures. Procurement specifications here demand ultra-purified raw materials free from solvent residues, exceeding commercial retail grade.
Local contract formulators require third-party HPLC-MS verified precursor materials (Nicotinamide Mononucleotide, Nicotinamide Riboside Chloride) that seamlessly integrate with complex biological carriers and lipid dispersion delivery architectures.
In the domestic Korean market, simple standalone nicotinamide salts face stiff price erosion. Brand managers in Daejeon increasingly formulate multi-target stacks pairing direct precursors with natural CD38 inhibitors and Sirtuin 1/3 allosteric activators.
By preventing rapid precursor catabolism into nicotinamide via CD38 hydrolyzation, advanced products retain cellular bioavailability over 24-hour intervals, appealing directly to discerning high-income biohackers and aging professionals.
Navigating the Ministry of Food and Drug Safety (MFDS) regulatory frameworks requires meticulous batch-to-batch repeatability and analytical paperwork. Overseas factories exporting to Daejeon-based distributors must operate under verified NSF 455-2 GMP regimes.
Our operational pipeline provides full elemental assay data via ICP-MS, residual volatile organic compounds (VOC) assessments, and irradiated material screening to simplify Korean customs clearance and specialized packaging approval.
Comprehensive breakdown of specialized OEM capsule architectures designed for clinical distribution, longevity clinics, and e-commerce brands in South Korea.
Engineered explicitly for technical professionals subject to severe mental workload and chronic oxidative strain throughout Daejeon's Daedeok Science Valley. This formulation focuses on cerebral energy currency replenishment without initiating secondary autonomic stress.
By blending beta-nicotinamide precursors with Magnesium L-Threonate and standardized Ginkgo extract, the capsule targets micro-capillary vasodilation and neuronal ATP maintenance, stabilizing midday mental focus without nervous system agitation.
Formulated for Daejeon aesthetic medicine institutes, anti-aging clinics, and private concierge wellness practices specializing in biological age deceleration. Designed to replenish NAD pools while driving SIRT1 and nuclear DNA repair pathways.
This formulation couples pure precursors with trans-resveratrol and Urolithin A to stimulate parallel cellular cleanup processes: autophagy of dysfunctional mitochondria alongside active PARP-1 DNA chain repairs.
A specialized nocturnal protocol tailored to mitigate the effects of modern urban blue-light pollution and disrupted sleep architecture on hepatic NAD cycles. Focuses on preventing precursor degradation by dampening excessive nocturnal inflammatory markers.
Utilizes Apigenin and bioavailable Magnesium Glycinate to simultaneously suppress the NAD-degrading ectoenzyme CD38 and stimulate parasympathetic nervous tone, promoting regenerative non-REM cycles.
Why Tier-1 Korean pharmaceutical intermediaries prioritize verified factory direct integrations over traditional intermediary sourcing.
| Evaluation Parameter | ESNO Biotech Verified Standard | Commodity Exporters / Wholesale Intermediaries |
|---|---|---|
| Precursor Crystallinity & Polymorphs | Controlled crystalline structure (Type II), optimized bulk density (0.45–0.60 g/mL) for automated filling. | Unmilled amorphous powders prone to air caking, inconsistent dosing, and rapid oxidation. |
| Hygroscopicity & Moisture Index | Karl Fischer Titration moisture < 0.5%; Water Activity (Aw) consistently under 0.05. | Moisture levels > 2.0%, accelerating hydrolytic cleavage into nicotinamide during maritime transit. |
| Heavy Metal Limits (ICP-MS) | Pb < 0.5 ppm, As < 0.5 ppm, Cd < 0.2 ppm, Hg < 0.1 ppm (Strict compliance with Korean MFDS). | Tested only to standard food thresholds (often < 2.0–5.0 ppm), creating import quarantine hazards. |
| Encapsulation Environment | Cleanrooms certified to Class 100,000 (ISO 8), with humidity stringently stabilized below 30% RH. | Non-climate-controlled spaces leading to rapid degradation of hydro-sensitive coenzymes. |
| Packaging Hermeticity | Induction-sealed pharma-grade amber PET or borosilicate glass bottles with active molecular sieve desiccant. | Standard blister or non-barrier plastic packaging permitting atmospheric moisture infiltration. |
Actionable consumer behavior insights and formula evolution dynamics governing high-conversion brands across the metropolitan Daejeon area and nationwide digital channels.
Korean consumers have shifted decisively from reactionary medical treatments to proactive, biological-age reduction strategies—commonly trending as "Slow-Aging" (저속노화). Formulations must substantiate tangible cellular recovery benefits rather than surface-level aesthetic promises.
Monotherapy is obsolete in the Korean premium sector. Successful brands launched out of Daejeon pair precursor molecules with mitochondrial antioxidants (PQQ, Ergothioneine) and natural methyl donors to deliver holistic cellular longevity support in a single daily dose.
Korean consumers rigorously analyze excipient profiles, demanding products free from magnesium stearate, silicon dioxide, and artificial colorants. Clean-label fillers such as organic rice concentrate and acacia fiber command top market prices on platforms like Naver SmartStore and Coupang.
Leveraging customs clearance through Incheon and Pyeongtaek, Daejeon entities increasingly utilize rapid air and sea-freight conduits to maintain fresh inventory directly from our Shaanxi facilities, reducing domestic warehouse overhead and maximizing product shelf-life.
Combining 19 years of primary botanical extraction, organic syntheses, and cleanroom encapsulation under strict global compliance oversight.
Our manufacturing complex in Xi’an is fully audited under NSF 455-2 GMP, ISO 22000, and HACCP standards, verified on-site by TÜV Rheinland. We guarantee total document transparency for your customs inspections, including fully verifiable COAs, batch records, and allergen declarations.
With more than 400 completed commercial formulas and 3,500+ global accounts served, our internal R&D laboratory provides tailored blending, pilot prototyping, organoleptic stabilization, and localized bilingual packaging that complies with target market labeling mandates.
Whether you require pilot validation runs of 100–500 units for regional clinical trials in Yuseong-gu or industrial-scale contract manufacturing yielding hundreds of thousands of bottles monthly, our high-speed automated packaging and blistering lines deliver rapid turnaround times.
Key regulatory, analytical, and supply chain questions answered by our export logistics specialists.
Our baseline minimum order quantity for standard stock private-label formulations begins at just 100 to 500 bottles. For completely custom formulations featuring specialized imported excipients, enteric capsules, or bespoke multi-compound premixes, baseline batches typically start at 1,000 units. We provide tiered sample runs for pilot clinical trials or regional market testing in Daejeon.
NAD precursors are naturally hygroscopic and susceptible to ambient hydrolysis. We mitigate this risk using a multi-step moisture defense system: Class 100,000 cleanrooms maintained below 30% relative humidity, pharmaceutical-grade low-moisture HPMC shells, active molecular sieve desiccant canisters, and high-frequency induction sealing. Every container is hermetically sealed to maintain an internal Water Activity (Aw) under 0.05.
Yes. Every production run is supplied with a comprehensive Certificate of Analysis (COA) specifying HPLC purity, optical rotation, residual solvents (compliant with USP/EP limits), and ICP-MS quantitative heavy metal screens for Lead, Arsenic, Cadmium, and Mercury. Additional stability testing, non-irradiation declarations, and full BSE/TSE-free certifications are available on request.
We supply traditional bovine gelatin, vegetarian HPMC, pullulan, and specialized acid-resistant enteric capsules. For NAD-enhancing compounds susceptible to gastric degradation, we recommend delayed-release HPMC shells that bypass the low pH environment of the stomach to optimize target duodenal assimilation without synthetic chemical enteric coatings.
Yes. Our in-house design studio collaborates directly with your team to deliver fully compliant packaging layouts, including bilingual English-Korean labels, precise metric conversions, nutritional panels, barcode generation, and secondary packaging, including embossed rigid boxes and tamper-evident outer cartons.
Standard lead times for private label production range from 15 to 25 business days following formula finalization and artwork approval. Shipments dispatched from our facilities to Incheon or Pyeongtaek ports via air freight arrive within 2–4 business days, while standard ocean freight delivers to bonded warehouses within 7–10 days, followed by domestic transit to Daejeon.
Consult with our technical R&D specialists to develop custom NAD formulations, request batch-specific analytical COAs, and secure rapid pilot production quotes today.
Inquire Now